Horizon Therapeutics

Horizon Therapeutics is a healthcare company dedicated to making a meaningful difference for patients and communities in need. It was founded in 2008 by CEO Tim Walbert, who himself had been diagnosed with a rare autoimmune condition. Horizon aims to deliver medicines for rare, autoimmune and severe inflammatory diseases and provide compassionate support.

Horizon has grown from a small team of employees to a global healthcare provider with over 2,000 employees worldwide and more than 100 patient advocacy group partnerships. Additionally, Horizon has over 60 community partners, demonstrating their commitment to making a difference in those affected by rare diseases.

Horizon believes that science and compassion must work together to transform lives. They strive to think differently when it comes to research and development to deliver treatments for the patients and communities they serve. They understand that many of those affected by rare diseases have limited options, so they have committed to responsible pricing and advocacy.

Horizon has developed a strong corporate culture committed to providing quality and compassionate care. They are dedicated to providing resources, support, and access to their medicines, and they understand the importance of giving back to the communities in which they live and work.

Founded: 2005

Headquarters: Dublin, Ireland

Website: https://horizontherapeutics.com